These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22522858)

  • 21. The pleiotropic actions of vitamin D.
    Lin R; White JH
    Bioessays; 2004 Jan; 26(1):21-8. PubMed ID: 14696037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
    Brown AJ; Ritter CS; Knutson JC; Strugnell SA
    Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin D.
    Vanoirbeek E; Eelen G; Verlinden L; Carmeliet G; Mathieu C; Bouillon R; O'Connor R; Xiao G; Verstuyf A
    Oncogene; 2014 Apr; 33(15):1904-11. PubMed ID: 23584482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of human breast carcinoma cells by a novel vitamin D analog: 1alpha-hydroxyvitamin D5.
    Mehta RR; Bratescu L; Graves JM; Green A; Mehta RG
    Int J Oncol; 2000 Jan; 16(1):65-73. PubMed ID: 10601550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D and cancer.
    Bouillon R; Eelen G; Verlinden L; Mathieu C; Carmeliet G; Verstuyf A
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):156-62. PubMed ID: 17113979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D compounds: activity against microbes and cancer.
    Gombart AF; Luong QT; Koeffler HP
    Anticancer Res; 2006; 26(4A):2531-42. PubMed ID: 16886661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent progress of study on vitamin D analogs].
    Kittaka A; Saito N; Takano M
    Clin Calcium; 2006 Jul; 16(7):1154-65. PubMed ID: 16816476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
    Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
    Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.
    Chiang KC; Yeh CN; Chen HY; Lee JM; Juang HH; Chen MF; Takano M; Kittaka A; Chen TC
    Steroids; 2011 Dec; 76(13):1513-9. PubMed ID: 21888924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D and colon cancer.
    Pereira F; Larriba MJ; Muñoz A
    Endocr Relat Cancer; 2012 Jun; 19(3):R51-71. PubMed ID: 22383428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells.
    Fernandez-Garcia NI; Palmer HG; Garcia M; Gonzalez-Martin A; del Rio M; Barettino D; Volpert O; Muñoz A; Jimenez B
    Oncogene; 2005 Sep; 24(43):6533-44. PubMed ID: 16007183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase.
    Bini F; Frati A; Garcia-Gil M; Battistini C; Granado M; Martinesi M; Mainardi M; Vannini E; Luzzati F; Caleo M; Peretto P; Gomez-Muñoz A; Meacci E
    Neuropharmacology; 2012 Sep; 63(4):524-37. PubMed ID: 22579669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D analogs and breast cancer.
    O'Kelly J; Koeffler HP
    Recent Results Cancer Res; 2003; 164():333-48. PubMed ID: 12899532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of vitamin D in prostate cancer.
    Zhao XY; Feldman D
    Steroids; 2001; 66(3-5):293-300. PubMed ID: 11179737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms for the selective action of Vitamin D analogs.
    Bouillon R; Verlinden L; Eelen G; De Clercq P; Vandewalle M; Mathieu C; Verstuyf A
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):21-30. PubMed ID: 16111885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular aspects of antineoplasic action of vitamin D].
    Bohl LP; Liaudat AC; Picotto G; Tolosa de Talamoni NG
    Rev Fac Cien Med Univ Nac Cordoba; 2008; 65(1):17-22. PubMed ID: 20803935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D analogues.
    Brown AJ
    Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S25-39. PubMed ID: 9808141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.